openPR Logo
Press release

Mesenchymal Stem Cells Market Outlook 2031: From US$ 3.2 Billion in 2022 to Over US$ 10.1 Billion by 2031, Driven by Regenerative Medicine Advancements and Rising Disease Prevalence

07-08-2025 06:43 AM CET | Health & Medicine

Press release from: Transparency Market Research

Mesenchymal Stem Cells Market

Mesenchymal Stem Cells Market

The global Mesenchymal Stem Cells (MSCs) Market, valued at US$ 3.2 billion in 2022, is projected to grow at a robust compound annual growth rate (CAGR) of 12.7% from 2023 to 2031, surpassing US$ 10.1 billion by 2031. MSCs, multipotent stem cells derived from bone marrow, adipose tissue, and umbilical cord, are used in regenerative medicine for conditions like osteoarthritis, cardiovascular diseases, and autoimmune disorders. The market's growth is driven by advancements in regenerative therapies, increasing prevalence of chronic diseases, and growing R&D investments. However, challenges such as high costs, regulatory complexities, and ethical concerns persist. This report provides a comprehensive analysis of the market, covering its overview, key drivers, challenges, regional insights, and future opportunities.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26735

Market Overview

The MSCs Market includes MSC-based therapies, products (e.g., cell lines, kits), and services for applications in orthopedics, cardiology, and neurology. Valued at US$ 3.2 billion in 2022, the market is expected to exceed US$ 10.1 billion by 2031, driven by a CAGR of 12.7%. It is segmented by source (bone marrow, adipose tissue, umbilical cord, others), product type (cell-based therapies, research products), application (orthopedic, cardiovascular, neurological, others), end-user (hospitals, research institutes, biotech companies), and region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa). Bone marrow-derived MSCs dominate due to established use, while research institutes lead as end-users.

Key Drivers of Growth

Several factors are propelling the growth of the MSCs Market:

Advancements in Regenerative Medicine: Over 1,000 MSC clinical trials globally in 2022, targeting conditions like osteoarthritis and spinal injuries, drive market growth.

Rising Chronic Disease Prevalence: Increasing cases of osteoarthritis (affecting 528 million people globally) and cardiovascular diseases boost demand for MSC therapies.

Growing R&D Investments: Biotech funding for MSC research, reaching US$ 2.5 billion in 2022, supports development of novel therapies.

Regulatory Support: Fast-track designations and orphan drug status for MSC therapies by the FDA and EMA accelerate market entry.

Aging Population: The global elderly population, projected to reach 1.4 billion by 2030, increases demand for regenerative treatments for age-related conditions.

Top Companies:

Thermo Fisher Scientific, Inc.
Cytiva (Danaher Corporation)
FUJIFILM Irvine Scientific (FUJIFILM Corporation)
Merck KGaA
Lonza Group Ltd.
STEMCELL Technologies, Inc.
Takara Bio, Inc.
Sartorius AG
Miltenyi Biotec GmbH and
PromoCell GmbH

Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/mesenchymal-stem-cells-market.html

Challenges and Barriers

Despite its growth potential, the market faces several challenges:

High Development Costs: MSC therapies, costing $10,000-$50,000 per treatment, limit accessibility in low-income regions.

Regulatory Complexities: Stringent regulations for cell-based therapies, requiring extensive clinical trials, increase costs and delay approvals.

Ethical Concerns: Use of certain MSC sources, like umbilical cord, raises ethical debates, potentially impacting public acceptance.

Limited Infrastructure in Developing Regions: Inadequate biotech facilities in Africa and parts of Asia-Pacific restrict market penetration.

Manufacturing Challenges: Scaling up MSC production while maintaining consistency and potency remains technically complex and costly.

Regional Insights

The MSCs Market exhibits distinct regional dynamics:

North America: Dominates with a 40% share in 2022, driven by advanced biotech infrastructure, high R&D spending, and FDA approvals. The U.S. leads due to major players like Mesoblast.

Europe: Holds a significant share, with Germany, France, and the UK benefiting from strong research networks and supportive regulations.

Asia-Pacific: Fastest-growing region, fueled by rising clinical trials, biotech investments, and growing disease prevalence in China, Japan, and India.

Latin America: Shows moderate growth, with Brazil and Mexico leading due to improving biotech infrastructure. Cost barriers limit adoption.

Middle East & Africa: Smallest share due to limited biotech facilities. Growth opportunities exist in Gulf countries with rising investments.

Future Opportunities

The MSCs Market offers several avenues for growth and innovation:

Allogeneic MSC Therapies: Developing off-the-shelf MSC products could improve scalability and reduce costs, driving market demand.

Expansion in Emerging Markets: Increasing biotech investments in Asia-Pacific and Latin America present opportunities for affordable MSC therapies.

Combination Therapies: Integrating MSCs with gene editing or biomaterials could enhance therapeutic efficacy.

AI-Driven Research: AI for optimizing MSC production and clinical trial design could reduce costs and accelerate development.

Partnerships with Biotech Firms: Collaborations can streamline R&D, manufacturing, and commercialization, boosting market reach.

Browse More Trending Research Reports:

Liquid Filled Hard Capsules Market: https://www.globenewswire.com/news-release/2023/7/4/2699010/0/en/Liquid-Filled-Hard-Capsules-Market-to-Grow-at-a-CAGR-of-7-8-from-2022-to-2031-reaching-US-4-0-billion-As-per-TMR-Study.html

Oral Rehydration Solution [ORS] Market: https://www.globenewswire.com/news-release/2023/10/05/2755222/32656/en/Oral-Rehydration-Solution-ORS-Market-to-Exceed-USD-6-71-billion-by-2031-Capturing-a-9-9-CAGR-TMR-Report.html

Atopic Dermatitis Drugs Market: https://www.globenewswire.com/news-release/2023/07/31/2715115/32656/en/Atopic-Dermatitis-Drugs-Market-to-Grow-at-a-CAGR-of-14-7-from-2022-to-2031-reaching-USD-29-4-Billion-As-per-TMR-Study.html

Oligonucleotides Market: https://www.globenewswire.com/news-release/2024/12/02/2989923/32656/en/Oligonucleotides-Market-Outlook-2034-Projected-to-Reach-US-13-1-Billion-by-2034-Driven-by-Expanding-Applications-in-Biotechnology-and-Precision-Medicine-TMR.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mesenchymal Stem Cells Market Outlook 2031: From US$ 3.2 Billion in 2022 to Over US$ 10.1 Billion by 2031, Driven by Regenerative Medicine Advancements and Rising Disease Prevalence here

News-ID: 4094982 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for MSC

Cruise Tourism Market Worth Observing Growth | Disney, MSC Cruises, NCL
A new business intelligence report released by HTF MI with title "Global Cruise Tourism Market Size, Status and Forecast 2018-2025" is designed covering micro level of analysis by manufacturers and key business segments. The Global Cruise Tourism Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and
Cruise Market is Booming Worldwide | Carnival , RCI , NCLH , MSC
HTF Market Intelligence released a new research report of 121 pages on title 'Global Cruise Market Report 2018' with detailed analysis, forecast and strategies. The study covers key regions that includes North America Country (United States, Canada) , South America , Asia Country (China, Japan, India, Korea) , Europe Country (Germany, UK, France, Italy) , Other Country (Middle East, Africa, GCC) and important players such as Carnival , RCI
Global Cruise Market By Key Players: RCI,NCLH,MSC,Disney
Qyresearchreports include new market research report "Global Cruise Market Professional Survey Report 2018" to its huge collection of research reports. This report studies the global Cruise market status and forecast, categorizes the global Cruise market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East
MSC Recognizes EAC Network at Breakfast of Champions
EAC Network received a Certificate of Appreciation from MSC at their second annual Breakfast of Champions event, which recognizes the Long Island company’s local nonprofit partners. MSC is a leading North American distributor of maintenance, repair, and operations products and services based in Melville, NY. The company has built strong partnerships with local and national nonprofit organizations throughout its 75-year history. MSC has supported EAC Network significantly through funding since
FDM Honours First FDM MSc Programme Graduate
The UK’s leading IT graduate employer, FDM Group, has honoured its first graduate from the FDM MSc Programme at the Brighton Dome. The graduation ceremony, held on 28th July, saw FDM Trainer Kevin Wright accept his Master’s in Applied Computer Science from University of Brighton. FDM fully-funded the course, which he studied via distance learning alongside his day job with the company. Developed in partnership with University of Brighton,
Info Session - MSc Program Engineering Management
Your key to the top engineeRing league! On May 8, 2008 the info session for the MSc Program Engineering Management takes place at the Vienna University of Technology. This part-time MSc Program is tailor-made for Europe`s small and medium-sized enterprises facing a growing and increasingly competitive market. It is design to prepare graduates from technical and economic universities for leadership roles in technical, corporate and national affairs. The Academic Director Prof. DDr.